Recent Press Releases

FACT SHEET: President Obama's Precision Medicine Initiative

Building on President Obama's announcement in his State of the Union Address, today the Administration is unveiling details about the Precision Medicine Initiative, a bold new research effort to...

AstraZeneca, MD Anderson Enter Collaboration to Help Improve Patient Outcomes in Ovarian/ Gynecologic Cancers

WILMINGTON, Del. & HOUSTON, Jan 29, 2015 -- AstraZeneca and The University of Texas MD Anderson Cancer Center today announced a multi-year, strategic research collaboration to conduct multiple,...

TRACON Pharmaceuticals Announces Pricing of Initial Public Offering

SAN DIEGO, Jan. 30, 2015 -- TRACON Pharmaceuticals, Inc. today announced the pricing of its initial public offering of 3,600,000 shares of common stock at a price to the public of $10.00 per share....

Alexion Pharmaceuticals Inc. (ALXN) Turns to Profit in Q4; Appoints New CEO

Alexion Appoints David L. Hallal as Chief Executive Officer, Effective April 1, 2015 Leonard Bell, M.D. Announces His Plans to Retire as CEO Dr. Bell to Continue as Chairman CHESHIRE,...

bluebird bio Announces Transition of Chief Scientific Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases, today...

CEO Bruno Lucidi Leaves Karolinska Development AB And Deputy CEO Terje Kalland Is Appointed Acting CEO

Stockholm - January 28, 2015. Karolinska Development AB today announced that the company's CEO Bruno Lucidi leaves the company. He is replaced by Deputy CEO Terje Kalland until a new, permanent...

Essen BioScience, Inc. Appoints Jim Ryder As Global Head Of Sales

Essen BioScience, Inc. ("Essen" or the Company), a leading provider of critical analytical instrumentation, software, reagents and services used in cell-based life science research, is...

Dimension Therapeutics Appoints Successful Biopharma Leader Mary Thistle As Chief Business Officer

Dimension Therapeutics, Inc. ("Dimension" or the "Company"), a rare disease company advancing novel treatments for diverse genetic disorders of the liver based upon an AAV gene therapy platform,...

Crown Bioscience, Inc. Strengthens Pre-Clinical Leadership Team With Senior Appointment

Santa Clara, CA (28th January 2015) – Crown Bioscience, Inc., a leading global drug discovery and development service company has announced the appointment of Laurie Heilmann as the new Senior...

Certara Corporation Promotes Professor Amin Rostami To Senior Vice President Of R&D And Chief Scientific Officer

PRINCETON, NJ – Jan. 29, 2015 – Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that it has promoted Amin...

Acurian, Inc. Announces Appointment Of Roger Smith As Senior Vice President And General Manager

Acurian Inc., a leading, full-service provider of global patient enrollment and retention solutions and a subsidiary of PPD, announced today that Roger Smith, formerly senior vice president of...

Spark Therapeutics Announces Pricing of Its Initial Public Offering

Spark Therapeutics Announces Pricing of Its Initial Public Offering PHILADELPHIA, Jan. 30, 2015 /PRNewswire/ -- Spark Therapeutics announced today the pricing of its initial public offering of...

Gilead Sciences, Inc. (GILD) Announces Executive Promotions

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the promotion of Andrew Cheng, MD, PhD to Executive Vice President, HIV Therapeutics and Development Operations, and Taiyin Yang, PhD, to the role...

Epizyme (EPZM) Appoints Robert A. Copeland, Ph.D., As President Of Research

Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced that Robert A....

Cerulean Pharma Inc. (CERU) Appoints Vice President, Clinical Operations

Cerulean Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting™, today announced the appointment of Tiffany Crowell as Vice President, Clinical Operations. "Tiffany comes to...

Cleveland Biolabs Inc. (CBLI) Announces Board Appointment

BUFFALO, NY--(Marketwired - January 28, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the appointment of Elena Kasimova of BioProcess Capital Partners to the Company's Board of...

Kevin Fitzpatrick Named Chief Innovation Officer of the American College Of Cardiology

WASHINGTON, Jan. 26, 2015 /PRNewswire-USNewswire/ -- Kevin Fitzpatrick has been named Executive Vice President and Chief Innovation Officer of the American College of Cardiology, a move that signals...

Ajaz S. Hussain is New Executive Director of National Institute for Pharmaceutical Technology and Education (NIPTE)

MINNEAPOLIS--(BUSINESS WIRE)--The National Institute for Pharmaceutical Technology and Education, Inc. (NIPTE) is pleased to announce the appointment of Ajaz Hussain, Ph.D., as its new executive...

Mast Therapeutics (MSTX) Announces Management Change

SAN DIEGO, Jan. 24, 2015 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a clinical-stage biopharmaceutical company, today announced a management change in connection with a restructuring...

Paragon Bioservices Announces Management Team Additions

BALTIMORE, Jan. 26, 2015 /PRNewswire/ -- Paragon Bioservices, Inc., a contract research and GMP manufacturing organization with a focus on the development and manufacturing of biopharmaceuticals,...